What is the maximum recommended dose of Ramipril (Angiotensin-Converting Enzyme (ACE) inhibitor)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Recommended Dose of Ramipril

The maximum recommended dose of ramipril is 20 mg per day for hypertension and 10 mg per day (5 mg twice daily) for heart failure post-myocardial infarction. 1

Hypertension Dosing

  • For hypertension, ramipril dosing ranges from 2.5 mg to 20 mg per day, administered as a single dose or in two equally divided doses 1
  • The initial dose is 2.5 mg once daily in patients not receiving a diuretic, with titration based on blood pressure response 1
  • If the antihypertensive effect diminishes toward the end of the dosing interval with once-daily administration, consider increasing the dose or switching to twice-daily administration 1
  • Clinical trials demonstrate that ramipril 2.5 to 20 mg daily effectively reduces and maintains blood pressure control during long-term treatment 2
  • In real-world practice, 81% of hypertensive patients required ≤5 mg once daily for adequate blood pressure control 3

Heart Failure Post-Myocardial Infarction Dosing

  • For heart failure post-MI, the target dose is 5 mg twice daily (10 mg total daily dose), with a starting dose of 2.5 mg twice daily 1
  • Patients who become hypotensive may be switched to 1.25 mg twice daily initially 1
  • Titrate upward toward the target dose over approximately 3-week intervals after one week at the starting dose 1
  • The maximum dose in this indication is lower than hypertension due to the increased risk of hypotension in post-MI heart failure patients 1

Special Populations Requiring Dose Adjustment

Renal Impairment

  • For patients with creatinine clearance >40 mL/min, use usual dosing regimens 1
  • For patients with creatinine clearance ≤40 mL/min, 25% of the usual dose produces full therapeutic levels of the active metabolite ramiprilat 1
  • In hypertensive patients with renal impairment, start at 1.25 mg once daily and titrate to a maximum of 5 mg daily 1
  • In heart failure patients with renal impairment, start at 1.25 mg once daily, increase to 1.25 mg twice daily, with a maximum of 2.5 mg twice daily 1

Volume Depletion or Renal Artery Stenosis

  • If volume depletion or renal artery stenosis is suspected, initiate dosing at 1.25 mg once daily regardless of indication 1
  • This lower starting dose reduces the risk of excessive hypotension in these high-risk scenarios 1

Clinical Context from Major Trials

  • The HOPE trial used ramipril 10 mg daily and demonstrated significant cardiovascular benefits, including reduction in MI, stroke, or cardiovascular death (RR 0.75, p=0.0004) 4
  • Lower doses (ramipril 1.25 mg daily) in the Marre 2004 study showed no significant mortality benefit, highlighting the importance of adequate dosing 4
  • Ramipril 10 mg once daily shows comparable antihypertensive efficacy to usual therapeutic dosages of captopril, enalapril, and atenolol 2, 5

Important Safety Considerations

  • Avoid concomitant use with potassium supplements, potassium salt substitutes, or potassium-sparing diuretics, as this increases the risk of hyperkalemia 1
  • Observe patients for at least 2 hours after the initial dose and until blood pressure stabilizes for an additional hour, particularly in heart failure patients 1
  • Consider reducing concomitant diuretic doses when initiating ramipril to minimize hypotension risk 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.